- Home
- JAGX vs PAVM Comparison
JAGX vs PAVM Comparison
Compare JAGX & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- PAVM
- Stock Information
- Founded
- JAGX 2013
- PAVM 2014
- Country
- JAGX United States
- PAVM United States
- Employees
- JAGX N/A
- PAVM N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- JAGX Health Care
- PAVM Health Care
- Exchange
- JAGX Nasdaq
- PAVM Nasdaq
- Market Cap
- JAGX 3.5M
- PAVM 12.0M
- IPO Year
- JAGX N/A
- PAVM 2016
- Fundamental
- Price
- JAGX $2.61
- PAVM $0.56
- Analyst Decision
- JAGX Strong Buy
- PAVM Strong Buy
- Analyst Count
- JAGX 1
- PAVM 1
- Target Price
- JAGX $60.00
- PAVM $19.00
- AVG Volume (30 Days)
- JAGX 85.4K
- PAVM 151.6K
- Earning Date
- JAGX 08-12-2025
- PAVM 08-11-2025
- Dividend Yield
- JAGX N/A
- PAVM N/A
- EPS Growth
- JAGX N/A
- PAVM N/A
- EPS
- JAGX N/A
- PAVM 0.96
- Revenue
- JAGX $11,552,000.00
- PAVM $1,993,000.00
- Revenue This Year
- JAGX $22.41
- PAVM N/A
- Revenue Next Year
- JAGX $30.00
- PAVM $455.63
- P/E Ratio
- JAGX N/A
- PAVM $0.58
- Revenue Growth
- JAGX 13.93
- PAVM N/A
- 52 Week Low
- JAGX $2.43
- PAVM $0.55
- 52 Week High
- JAGX $110.75
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- JAGX 30.69
- PAVM 36.29
- Support Level
- JAGX $2.53
- PAVM $0.55
- Resistance Level
- JAGX $2.65
- PAVM $0.61
- Average True Range (ATR)
- JAGX 0.20
- PAVM 0.03
- MACD
- JAGX 0.12
- PAVM -0.00
- Stochastic Oscillator
- JAGX 19.54
- PAVM 4.47
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.